Download PDF
Kinder- und Jugendmedizin 2023; 23(06): 400-406
DOI: 10.1055/a-2177-9331
Schwerpunkt

Lichen sclerosus im Kindes- und Jugendalter

Ein unterdiagnostiziertes Krankheitsbild in der Kinder- und JugendgynäkologiePediatric Lichen sclerosus – a underdiagnosed disorder
Katharina Horn
1   Universitätsklinikum Leipzig AöR, Universitätsfrauenklinik
,
Nadja Dornhöfer
1   Universitätsklinikum Leipzig AöR, Universitätsfrauenklinik
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

ZUSAMMENFASSUNG

Lichen sclerosus ist eine chronisch-entzündliche Erkrankung der Haut und Schleimhäute, die insbesondere im Anogenitalbereich, aber auch anderen Körperregionen auftreten kann. Die Ätiopathogenese ist bis heute nur unzureichend bekannt und vermutlich multifaktoriell. Im Vordergrund stehen immunologische und genetische Faktoren. Die ersten Symptome sind meistens unspezifisch: Juckreiz, Brennen, Schmerzen, Missempfindungen und Entzündung. Es kommt typischerweise im Verlauf zu Hautveränderungen der Anogenitalregion, die neben weißlicher Verfärbung und abnehmender Elastizität zu Narbenbildungen und einer veränderten Anatomie der Vulva führen kann. Langjähriger, unbehandelter vulvärer Lichen sclerosus ist außerdem ein Risikofaktor für die spätere Entstehung eines Vulvakarzinoms. Häufig kommt es aufgrund der unspezifischen Symptome im frühen Krankheitsstadium zu einer prolongierten Diagnosestellung. Die frühzeitige Einleitung einer spezifischen Therapie ist von wesentlicher Bedeutung, um zum einen die teils quälenden Symptome zu lindern und zum anderen den Langzeitfolgen entgegenzuwirken. Hier steht an erster Stelle die Therapie mit ultrapotenten Glukokortikoiden.

ABSTRACT

Lichen sclerosus is a chronic mucocutaneous inflammatory disease, which is predominantly located at the anogenital region, but can also appear at other body regions. The etiopathogenesis is still insufficiently known and probable multifactoriell. The first symptoms are mostly not specific: itching, burning sensation, pain, discomfort and inflammation. In the further course, skin alteration of the perianal region occurs. Beside demarcated white skin lesions and loss of elasticity, scarring and a distorted vulvar architecture can arise. Longterm, untreated vulvar lichen sclerosus is a risk factor for vulvar cancer. Because of the unspecific symptoms in the early stage of the disease, the diagnosis is often prolonged. The early beginning of a specific therapy is very important: to alleviate the excruciating symptoms on the on hand and to prevent complications on the other hand. The golden standard is the therapy with ultrapotent topical corticosteroids.

Schlüsselwörter

Lichen sclerosus - Kinder - Jugendliche

Key words

Lichen sclerosus - children - adolescent


Publication History

Article published online:
01 December 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG,
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Nerantzoulis I, Grigoriadis T, Michala L. Genital lichen sclerosus in childhood and adolescence – a retrospective case series of 15 patients: early diagnosis is crucial to avoid long-term sequelae. Eur J Pediatr 2017; 176: 1429-1432
    CrossrefPubMedSearch in Google Scholar
  • 2 Goldstein AT, Marinoff SC, Christopher K. et al Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med 2005; 50: 477-480
    PubMedSearch in Google Scholar
  • 3 Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol 2001; 44: 803-806
    CrossrefPubMedSearch in Google Scholar
  • 4 Jensen LS, Bygum A. Childhood lichen sclerosus is a rare but important diagnosis. Dan Med J 2012; 59: A4424
    PubMedSearch in Google Scholar
  • 5 Orszulak D, Dulska A, Niziński K. et al Pediatric Vulvar Lichen Sclerosus-A Review of the Literature. Int J Environ Res Public Health 2021: 18
    CrossrefPubMedSearch in Google Scholar
  • 6 Torres A, Zaborek-Łyczba M, Łyczba J. et al The Importance of Immunological Disorders in the Pathogenesis of Lichen Sclerosus in Pediatric Patients: A Systematic Review. Int J Mol Sci 2022: 23
    CrossrefPubMedSearch in Google Scholar
  • 7 Oyama N, Chan I, Neill SM. et al Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 2003; 362: 118-123
    CrossrefPubMedSearch in Google Scholar
  • 8 Krapf JM, Mitchell L, Holton MA. et al Vulvar Lichen Sclerosus: Current Perspectives. Int J Womens Health 2020; 12: 11-20
    CrossrefPubMedSearch in Google Scholar
  • 9 Klaber R. Lichen Sclerosus et Atrophicans (Hallopeau). Proc R Soc Med 1937; 30: 977-979
    PubMedSearch in Google Scholar
  • 10 Simpkin S, Oakley A. Clinical review of 202 patients with vulval lichen sclerosus: A possible association with psoriasis. Australas J Dermatol 2007; 48: 28-31
    CrossrefPubMedSearch in Google Scholar
  • 11 Cooper SM, Ali I, Baldo M. et al The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008; 144: 1432-1435
    CrossrefPubMedSearch in Google Scholar
  • 12 Powell J, Wojnarowska F, Winsey S. et al Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 2000; 142: 481-484
    CrossrefPubMedSearch in Google Scholar
  • 13 Baldo M, Bhogal B, Groves RW. et al Childhood vulval lichen sclerosus: autoimmunity to the basement membrane zone protein BP180 and its relationship to autoimmunity. Clin Exp Dermatol 2010; 35: 543-545
    CrossrefPubMedSearch in Google Scholar
  • 14 Sherman V, McPherson T, Baldo M. et al The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol 2010; 24: 1031-1034
    CrossrefPubMedSearch in Google Scholar
  • 15 Singh N, Ghatage P. Etiology, Clinical Features, and Diagnosis of Vulvar Lichen Sclerosus: A Scoping Review. Obstet Gynecol Int 2020; 2020: 7480754
    CrossrefPubMedSearch in Google Scholar
  • 16 Chakhtoura Z, Vigoureux S, Courtillot C. et al Vulvar lichen sclerosus is very frequent in women with Turner syndrome. J Clin Endocrinol Metab 2014; 99: 1103-1104
    CrossrefPubMedSearch in Google Scholar
  • 17 Kirtschig G. Lichen Sclerosus-Presentation, Diagnosis and Management. Dtsch Arztebl Int 2016; 113: 337-343
    CrossrefPubMedSearch in Google Scholar
  • 18 Chattopadhyay S, Arnold JD, Malayil L. et al Potential role of the skin and gut microbiota in premenarchal vulvar lichen sclerosus: A pilot case-control study. PLoS One 2021; 16: e0245243
    CrossrefPubMedSearch in Google Scholar
  • 19 Chen Y, Bruning E, Rubino J. et al Role of female intimate hygiene in vulvovaginal health: Global hygiene practices and product usage. Womens Health (Lond) 2017; 13: 58-67
    CrossrefPubMedSearch in Google Scholar
  • 20 Lagerstedt M, Karvinen K, Joki-Erkkilä M. et al Childhood lichen sclerosus – a challenge for clinicians. Pediatr Dermatol 2013; 30: 444-450
    CrossrefPubMedSearch in Google Scholar
  • 21 Ismail D, Owen CM. Paediatric vulval lichen sclerosus: a retrospective study. Clin Exp Dermatol 2019; 44: 753-758
    CrossrefPubMedSearch in Google Scholar
  • 22 Dendrinos ML, Quint EH. Lichen sclerosus in children and adolescents. Curr Opin Obstet Gynecol 2013; 25: 370-374
    CrossrefPubMedSearch in Google Scholar
  • 23 Loveless M, Myint O. Vulvovaginitis- presentation of more common problems in pediatric and adolescent gynecology. Best Pract Res Clin Obstet Gynaecol 2018; 48: 14-27
    CrossrefPubMedSearch in Google Scholar
  • 24 Kirtschig G, Becker K, Günthert A. et al Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. J Eur Acad Dermatol Venereol 2015; 29: e1-43
    CrossrefPubMedSearch in Google Scholar
  • 25 Dinh H, Purcell SM, Chung C. et al Pediatric Lichen Sclerosus: A Review of the Literature and Management Recommendations. J Clin Aesthet Dermatol 2016; 09: 49-54
    Search in Google Scholar
  • 26 Bigby SM, Eva LJ, Fong KL. et al The Natural History of Vulvar Intraepithelial Neoplasia, Differentiated Type: Evidence for Progression and Diagnostic Challenges. Int J Gynecol Pathol 2016; 35: 574-584
    CrossrefPubMedSearch in Google Scholar
  • 27 Jones RW, Sadler L, Grant S. et al Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: a case-control study. J Reprod Med 2004; 49: 808-811
    PubMedSearch in Google Scholar
  • 28 Bleeker MCG, Visser PJ, Overbeek LIH. et al Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma. Cancer Epidemiol Biomarkers Prev 2016; 25: 1224-1230
    CrossrefPubMedSearch in Google Scholar
  • 29 Halonen P, Jakobsson M, Heikinheimo O. et al Lichen sclerosus and risk of cancer. Int J Cancer 2017; 140: 1998-2002
    CrossrefPubMedSearch in Google Scholar
  • 30 Morrel B, van Eersel R, Burger CW. et al The long-term clinical consequences of juvenile vulvar lichen sclerosus: A systematic review. J Am Acad Dermatol 2020; 82: 469-477
    CrossrefPubMedSearch in Google Scholar
  • 31 Lee A, Bradford J, Fischer G. Long-term Management of Adult Vulvar Lichen Sclerosus: A Prospective Cohort Study of 507 Women. JAMA Dermatol 2015; 151: 1061-1067
    CrossrefPubMedSearch in Google Scholar
  • 32 Renaud-Vilmer C, Cavelier-Balloy B, Porcher R. et al Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol 2004; 140: 709-712
    CrossrefPubMedSearch in Google Scholar
  • 33 Winfrey OK, Fei YF, Dendrinos ML. et al Lichen Sclerosus throughout Childhood and Adolescence: Not Only a Premenarchal Disease. J Pediatr Adolesc Gynecol 2022; 35: 624-628
    CrossrefPubMedSearch in Google Scholar
  • 34 Smith SD, Fischer G. Childhood onset vulvar lichen sclerosus does not resolve at puberty: a prospective case series. Pediatr Dermatol 2009; 26: 725-729
    CrossrefPubMedSearch in Google Scholar
  • 35 Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus. The course after puberty. J Reprod Med 2002; 47: 706-709
    PubMedSearch in Google Scholar
  • 36 Lewis FM, Tatnall FM, Velangi SS. et al British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol 2018; 178: 839-853
    CrossrefPubMedSearch in Google Scholar
  • 37 Akel R, Fuller C. Updates in lichen sclerosis: British Association of Dermatologists guidelines for the management of lichen sclerosus 2018. Br J Dermatol 2018; 178: 823-824
    CrossrefPubMedSearch in Google Scholar
  • 38 Tong LX, Sun GS, Teng JMC. Pediatric Lichen Sclerosus: A Review of the Epidemiology and Treatment Options. Pediatr Dermatol 2015; 32: 593-599
    CrossrefPubMedSearch in Google Scholar
  • 39 Neill SM, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol 2002; 147: 640-649
    CrossrefPubMedSearch in Google Scholar
  • 40 Neill SM, Lewis FM, Tatnall FM. et al British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol 2010; 163: 672-682
    CrossrefPubMedSearch in Google Scholar
  • 41 Bercaw-Pratt JL, Boardman LA, Simms-Cendan JS. Clinical recommendation: pediatric lichen sclerosus. J Pediatr Adolesc Gynecol 2014; 27: 111-116
    CrossrefPubMedSearch in Google Scholar
  • 42 Simms-Cendan J, Hoover K, Marathe K. et al NASPAG Clinical Opinion: Diagnosis and Management of Lichen Sclerosis in Pediatric and Adolescent Patients. J Pediatr Adolesc Gynecol 2022; 35: 112-120
    CrossrefPubMedSearch in Google Scholar
  • 43 Casey GA, Cooper SM, Powell JJ. Treatment of vulvar lichen sclerosus with topical corticosteroids in children: a study of 72 children. Clin Exp Dermatol 2015; 40: 289-292
    CrossrefPubMedSearch in Google Scholar
  • 44 Notay M, Fazel N, Awasthi S. Cushing Syndrome Induced by Topical Corticosteroids for the Treatment of Lichen Sclerosus. J Pediatr Adolesc Gynecol 2019; 32: 83-85
    CrossrefPubMedSearch in Google Scholar
  • 45 Ellis E, Fischer G. Prepubertal-Onset Vulvar Lichen Sclerosus: The Importance of Maintenance Therapy in Long-Term Outcomes. Pediatr Dermatol 2015; 32: 461-467
    CrossrefPubMedSearch in Google Scholar
  • 46 Brodrick B, Belkin ZR, Goldstein AT. Influence of treatments on prognosis for vulvar lichen sclerosus: facts and controversies. Clin Dermatol 2013; 31: 780-786
    CrossrefPubMedSearch in Google Scholar
  • 47 Li Y, Xiao Y, Wang H. et al Low-concentration topical tacrolimus for the treatment of anogenital lichen sclerosus in childhood: maintenance treatment to reduce recurrence. J Pediatr Adolesc Gynecol 2013; 26: 239-242
    CrossrefPubMedSearch in Google Scholar
  • 48 Funaro D, Lovett A, Leroux N. et al A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05 % versus topical tacrolimus 0.1 % in patients with vulvar lichen sclerosus. J Am Acad Dermatol 2014; 71: 84-91
    CrossrefPubMedSearch in Google Scholar